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DOI 10.1016/j.ccr.2011.07.005SUMMARYIt is widely believed that the molecular and cellular features of a tumor reflect its cell of origin and can thus
provide clues about treatment targets. The retinoblastoma cell of origin has been debated for over a century.
Here, we report that human andmouse retinoblastomas havemolecular, cellular, and neurochemical features
of multiple cell classes, principally amacrine/horizontal interneurons, retinal progenitor cells, and photore-
ceptors. Importantly, single-cell gene expression array analysis showed that these multiple cell type-specific
developmental programs are coexpressed in individual retinoblastoma cells, which creates a progenitor/
neuronal hybrid cell. Furthermore, neurotransmitter receptors, transporters, and biosynthetic enzymes are
expressed in human retinoblastoma, and targeted disruption of these pathways reduces retinoblastoma
growth in vivo and in vitro.INTRODUCTION
Mouse models of cancer have become increasingly important in
the fields of cancer genetics and translational research. This is
particularly true for pediatric cancers, because the patient pop-
ulation is relatively small, and preclinical models are essential for
demonstrating the efficacy of new therapeutic approaches
before initiating clinical trials in children. In addition, animal
models of cancer can provide important insight into the molec-
ular, cellular, and genetic mechanisms underlying tumor initia-
tion and progression.Significance
Our finding that retinoblastoma tumor cells express multiple ne
ible in development suggests that the pathways that contro
perturbed during tumorigenesis. Therefore, the cell of origin
the tumor cells themselves. However, we now have a detailed u
in retinoblastoma and targeting the catecholamine and indola
useful therapeutic approaches in future studies. This examp
cellular, and physiological characterization of human cance
targeted therapy into treatment regimens.
260 Cancer Cell 20, 260–275, August 16, 2011 ª2011 Elsevier Inc.Onechallengeofmodelingpediatriccancer inmice is that these
tumors initiate in the context of developing tissues that change
rapidly, and the cells that give rise to the tumors can display an
extraordinary degree of plasticity and heterogeneity. This is
further complicated by the fact that many tumor suppressor
genes and proto-oncogenes play essential roles in regulating
cell fate specification and differentiation during development.
Specifically, the genetic lesions that contribute to tumor initiation
and progression may also alter the intrinsic cell fate specification
and differentiation programs in the tumor cells, thereby making it
very difficult to infer the cell of origin for that tumor.uronal differentiation programs that are normally incompat-
l retinal development and establish distinct cell types are
for retinoblastoma cannot be inferred from the features of
nderstanding of the neuronal pathways that are deregulated
mine receptors or downstream components could provide
le highlights the importance of comprehensive molecular,
rs with single cell resolution as we incorporate molecular
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Differentiation of RetinoblastomaAs therapeutic agents are developed to target particular
molecular pathways in cancer cells, identifying the cell of origin
becomes increasingly important. For example, if the cell of origin
of a pediatric cancer was a progenitor cell, a very different
strategy would be employed to target particular pathways in
that cell than if it was a highly specialized differentiated cell
from the same tissue. This is particularly true for tumors of the
central nervous system, because neurons are incredibly diverse
and use a variety of signal transduction pathways that may be
co-opted during tumorigenesis.
Retinoblastoma is a rare childhood cancer of the retina that
initiates during fetal development and is often diagnosed at birth
or during the first few years of life. The first attempt to formulate
a link between tumor cell features and a specific retinal cell
type (i.e., photoreceptors) as the cell of origin was in 1897 with
the description of retinoblastoma rosettes (Wintersteiner, 1897).
In subsequent decades, this hypothesis was extended to include
morphological analysis using transmission electron micros-
copy (TEM) (Dickson et al., 1976; Ts’o et al., 1970a; Ts’o et al.,
1970b), immunohistochemistry (arrestin and rhodopsin) (Donoso
et al., 1985, 1986; Mirshahi et al., 1986; Vrabec et al., 1989), and
immunofluorescence (Crx and opsin) (Glubrecht et al., 2009; Xu
et al., 2009). However, during this same period, data were pub-
lishedsuggesting that retinoblastomamayarise fromaprogenitor
cell (Beemer et al., 1984; Donovan et al., 2006; Glubrecht et al.,
2009; Kyritsis et al., 1984a, 1984b; Zhong et al., 2007), a glial
cell (Daa Schroder, 1987), or an interneuron such as an amacrine
cell (Johnsonet al., 2007;Kyritsis et al., 1986; Tsokoset al., 1986).
Despite all of these efforts over the past decades, we still do not
know which cell type(s) gives rise to retinoblastoma or if analysis
of the features of retinoblastoma tumors can shed light on the cell
of origin for this developmental tumor of the retina.
In this study, we performed comprehensive, unbiased molec-
ular, cellular, and neurochemical analyses of mouse and human
retinoblastoma cells to elucidate their detailed cellular signatures
and to determine how these signatures relate to those of normal
retinal cell types.
RESULTS
Human Retinoblastomas Have Similar Molecular
Profiles
To assemble a molecular profile of human retinoblastoma, we
carried out gene expression profiling of 52 fresh retinoblastomas
from patients who underwent surgical enucleation prior to anti-
cancer therapy (see Table S1 available online). For profile
comparisons, we also included four retinoblastoma cell lines
(Y79, Weri1, Rb-355, and Rb-13) (Griegel et al., 1990a; Griegel
et al., 1990b;McFall et al., 1977; Reid et al., 1974) in this analysis.
A principal component analysis (PCA) and hierarchical clustering
revealed that the majority of tumor samples (46/52, 88.5%)
cluster tightly around a central coremolecular signature; no clear
subtypes were detected (Figures 1A and 1B). Three tumors that
had the same coremolecular signature (SJRB-39, SJRB-41, and
SJRB-42) were introduced into the vitreous of immunocompro-
misedmice for future orthotopic xenograft studies. Transmission
electron microscopy (TEM) analysis of these three primary
tumors confirmed that they had many of the cellular features of
retinoblastoma, including mitotic figures, abundant mitochon-dria, cellular processes, and extensive cell-cell junctions (John-
son et al., 2007) (Figure 1C; Figure S1).
To gain insight into the differentiation features of human retino-
blastomas, we analyzed the expression of 28 genes from the
microarrays that are restricted to different retinal cell classes
(Figure 1D). A mixture of genes that are normally expressed in
retinal progenitor cells and differentiated retinal neurons (i.e.,
photoreceptors and amacrine cells) were expressed in human
retinoblastomas (Figure 1E). Real-time RT-PCR was used to
confirm these data (Figure 1F; data not shown). These results
together suggested that human retinoblastomas are relatively
homogenous and express a hybrid differentiation phenotype.
Mouse Retinoblastomas from Six Genotypes Show
Striking Similarities
We have generated six mouse lines that develop retinoblastoma
by using the Chx10-Cre to conditionally inactivated tumor
suppressor pathways in their developing retinae (Rowan and
Cepko, 2004) (Figures 2A–2F). Chx10-Cre;RbLox/Lox;p107/
(7D), Chx10-Cre;RbLox/Lox;p130/ (3D), Chx10-Cre;RbLox/Lox;
p107+/–;p130/ (p107s), and Chx10-Cre;RbLox/Lox;p107/;
p130Lox/Lox(RbTKO) develop retinoblastoma when different
combinations of Rb family members are inactivated in retinal
progenitor cells (Figures 2A–2D). Theother two strains developed
retinoblastoma when Rb-pathway inactivation was combined
with p53 pathway inactivation. The Chx10-Cre;RbLox/Lox;
p107/;p53Lox/Lox (p53TKO) mice lack p53, Rb, and p107, and
the Chx10-Cre;RbLox/Lox;p107/;MDMXTg (MDMX) mice condi-
tionally overexpress theMDMX gene (Xiong et al., 2010) in retinal
progenitor cells that lack Rb and p107 (Figures 2E and 2F).
To characterize tumor incidence and progression in these
mouse models of retinoblastoma, we monitored 509 mice
weekly from 3 weeks of age until advanced tumor progression
necessitated euthanasia (Figures 2A–2F). Retinal camera images
and fluorescein angiography of early-stage tumors (Figure 2G)
showed that in mice, retinoblastoma initiates in a manner similar
to that seen in humans. Tumors originate in multiple foci across
the retina and efficiently reorganize the retinal vasculature. The
time from tumor diagnosis to moribund status reflected the
ages at which the six strains developed advanced-stage retino-
blastoma (Figure 2H). This finding suggests that the difference
between strains was due to differences in the rate of tumor
progression rather than the rate of initiation. Histopathologic
analysis of five mice from each strain (60 eyes total) confirmed
that optic nerve, anterior chamber, subretinal, and choroidal
invasion were present in each strain (Figures S2A–S2F). Anterior
chamber and subretinal invasion was the most common (80%–
100% of eyes examined), and optic nerve and choroidal invasion
was the least common (30%–60% of eyes examined). Necropsy
on 22 of the p53TKO mice revealed that 23% (5/22) of the mice
had metastases. Four of the metastatic lesions were in the brain,
and one was in a lymph node, which is consistent with the
pattern seen in patients with metastatic retinoblastoma. All of
the mouse retinoblastoma strains displayed abundant rosettes,
except for the RbTKO strain, which had only a few areas with
rosettes (Figures 2I and 2J and data not shown).
We performed immunostaining for markers of proliferation
(Ki67), apoptosis (caspase 3), neuronal differentiation (Tuj1,
synaptophysin), astrocytes and activated Mu¨ller glia (GFAP),Cancer Cell 20, 260–275, August 16, 2011 ª2011 Elsevier Inc. 261
Figure 1. Molecular Characterization of Human Retinoblastoma Cells
(A) Principal component analysis (PCA) of gene expression array data from primary human retinoblastoma cells and four human retinoblastoma cell lines (Y79,
Weri1, RB-355, and RB-13). SJ-39, SJ-41, and SJ-42 were subsequently used as a source for orthotopic xenografts.
(B) Hierarchical cluster of human retinoblastoma and cell line gene expression array data. Black lines are those tumors used for orthotopic xenografts, and light
gray lines are the cell lines. All other lines (dark gray) are primary tumor samples.
(C) TEM of the primary tumor SJ-39. Arrows indicate invaginations in the nucleus (n) adjacent to a mitotic figure (m).
(D) Overview of retinal development from multipotent progenitor cells; representative cell type-restricted genes appear in the boxes.
(E) Box plots of the Log2 expression from the microarrays for a series of genes found in retinal progenitor cells, rod and cone photoreceptors, amacrine/ganglion/
horizontal cells, or bipolar/Mu¨ller cells. Each box includes the data for all 52 human gene expression arrays. The bottom and top of the boxes are the 25th and 75th
percentile and the line in the middle is the 50th percentile. The lines represent one standard deviation above and below the mean and data points outside of those
lines represent outliers.
(F) Real-time RT-PCR data using TaqMan probes of genes selected from (E). Each bar is the mean and standard deviation of triplicate samples. Abbreviations:
Adult, adult human retina; FW9, human fetal week 9; m, mitotic figure; n, nucleus.
See also Figure S1 and Table S1.
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Differentiation of Retinoblastomavascular endothelial cells (CD34), and macrophages (Mac2,
F4/80) on paraffin-embedded sections from five mice per geno-
type and scored the proportion of immunopositive cells (Figures
S2G–S2I). At the stage when these tumors were isolated
(moribund status), there were no dramatic differences across
strains in the expression of these markers by genotype. In
addition, TEM analysis of another 30 tumors across the six
genotypes indicated that there were no significant differences
in cellular morphology, including differentiation features such
as processes and junctions (Figure S2J).262 Cancer Cell 20, 260–275, August 16, 2011 ª2011 Elsevier Inc.To develop a molecular profile of our retinoblastoma mice, we
performed gene expression array analysis on 120 tumors (20 per
strain). When combined on a PCA plot, the six retinoblastoma
mouse strains exhibited extensive overlap and intermixing of
their gene expression profiles (Figure 2K). The gene expression
profiles were highly correlated (95%–99%) across all strains
but the most distinct were p53 TKO and Rb TKO (Figures S2K
and S2L and Table S2). The orthologs of the 28 genes used to
characterize the retinal differentiation properties of human reti-
noblastomas (Figure 1) were also coexpressed in the mouse
Figure 2. Characterization of Mouse Retinoblastoma Cells from Six Different Strains
(A–F) Kaplan-Meyer survival curves for 509 mice from six genotypes. The endpoint is moribund status, as defined by imminent ocular rupture. Abbreviations
for each genotype are indicated above each curve. The period required for 50% of mice from each strain to reach moribund status is indicated with a dashed
line.
(G) Representative images of mouse retinoblastomas and normal retinae tissue made by using a digital retinal camera and fluorescein angiography. Arrows
indicate tumor foci.
(H) Box plot of time from diagnosis to moribund status for a small cohort of 10–12 animals per genotype. The bottom and top of the boxes are the 25th and 75th
percentile and the line in the middle is the 50th percentile. The lines represent one standard deviation above and below themean and data points outside of those
lines represent outliers.
(I and J) Hematoxylin and eosin staining of a representative p107s (Rb/;p107+/–;p130/) tumor featuring rosettes with central plexi (arrows) and an RbTKO
(Rb/;p107/;p130/) tumor lacking a plexus. Scale bars: 25 mm.
(K) PCA of gene expression arrays for 120 mouse retinoblastomas (20 from each of the 6 indicated strains).
(L) Hierarchical cluster of mouse retinoblastomas with individual clusters designated by letters (a–k).
(M) PCA of mouse clusters from (L).
See also Figure S2 and Table S2 and Table S3.
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Differentiation of Retinoblastomaretinoblastomas (Figure S2M). Cell type scoring and real time
RT-PCR confirmed a hybrid molecular signature (Figures S2N
and S2O). Hierarchical cluster analysis (Figures 2L and 2M)
identified two clusters (j and k) that exhibited gene expression
differences in photoreceptor and amacrine/horizontal neuron
genes that were validated by real-time RT-PCR (Figures
S2P–S2S and Table S3). However, even in the clusters with
enriched gene expression of particular retinal differentiation
pathways, multiple developmental programs were coexpressed
(Figures S2P–S2S).Mouse and Human Retinoblastomas Share Molecular
Profiles
To directly compare the molecular signatures of human and
mouse retinoblastomas, we focused our analysis on the 15,646
unique ortholog-matched unigene pairs present on the human
and mouse gene expression arrays. There are three potential
sources of variance in comparing human and mouse array
data: (1) differences in individual probe sets of the ortholog-
matched unigenes; (2) general biological differences across
species; and (3) biological differences between human andCancer Cell 20, 260–275, August 16, 2011 ª2011 Elsevier Inc. 263
Figure 3. Comparison of Gene Expression in Human and Mouse Retinoblastoma
(A) PCA of mouse and human gene expression array data for the ortholog-matched unigene pairs.
(B) The view is rotated 90 around the y axis to show the overlay of the human and mouse data. The Rb TKO strain is encircled.
(C) The same view of the mouse-human PCA that is shown in (B), but the colors now reflect the hierarchical clusters. Cluster k represents the best match for
human retinoblastoma and is primarily made up of Rb TKO.
(D and E) Correlation table of human retinoblastoma, human retinoblastoma xenografts (SJ-39, SJ-41, SJ-42, and MSKCC 176), and human retinoblastoma cell
lines compared to each genotype (D) or cluster (E). The arrows indicate the best match, and the gray-shaded columns indicate the second-best match.
See also Table S4.
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Differentiation of Retinoblastomamouse tumors, which provide insight into the biology of retino-
blastoma and how well the mouse models recapitulate the
human disease.
To minimize the contribution of the first two sources of vari-
ance and highlight the major differences between the human
and mouse retinoblastomas, we developed an algorithm for
cross-species comparisons of array data (see Supplemental
Experimental Procedures). Using this method, we found that
12,267 of 15,646 (78%) ortholog-matched unigene pairs ex-
hibited similar levels of expression (<1 quartile difference) across
species. To establish the significance of this correlation, we
randomized the probe sets in a series of 50,000 simulations
per chip and performed the same analysis. These simulations
demonstrated that any correlation greater than 3.5% is signifi-
cant with a p value of at least 0.00002. The majority of the differ-
ences between human and mouse retinoblastoma unigene pairs
(3094/3379; 92%) was a 1-quartile difference in expression; 280
of 3379 (8.3%) were a 2-quartile difference; and 5 of 3379 (0.1%)
were a 3-quartile difference in expression. Among those unigene
pairs that were most distinct across species (p = 2.3 3 1017),
269 differed across all mouse genotypes (Table S4), and an addi-
tional 525 differed in subsets of the six genotypes (Table S4).
PCA analysis demonstrated that most of the difference
between the profiles of human and mouse retinoblastoma cells
was in a single dimension (Figure 3). A correlation analysis of
all mouse genotypes and clusters to human tumors indicated
that the RbTKO strain was the best match to human retinoblas-
tomas by a small margin (Figure 3).
Mouse and Human Retinoblastomas Express Multiple
Differentiation Pathways
To perform an unbiased analysis of retinal cell type molecular
signatures, we took advantage of a recent series of publications264 Cancer Cell 20, 260–275, August 16, 2011 ª2011 Elsevier Inc.using gene expression array analysis of individually isolated
retinal progenitor cells and differentiated retinal neurons and
glia (Cherry et al., 2009; Roesch et al., 2008; Trimarchi et al.,
2008). Cone photoreceptors have not been analyzed using this
single-cell technique, so we used in situ-validated microarray
data from purified pools of cone photoreceptors (Akimoto
et al., 2006).
Cell type signatures of retinal progenitor cells, rod photore-
ceptors, cone photoreceptors, amacrine cells, ganglion cells,
and Mu¨ller glia (Table S5) were used to characterize the differ-
entiation state of all 172 mouse and human retinoblastomas in
our microarray study, as described previously (Cherry et al.,
2009; Roesch et al., 2008; Trimarchi et al., 2008). We also
analyzed a group of previously characterized genes that regu-
late the G2/M phase of the cell cycle to compare the prolifera-
tion signature in the retinoblastomas to that of normal retinal
progenitor cells. The most robust cell type-specific signatures
for human retinoblastomas were those of progenitor cells,
G2/M genes, and rod photoreceptors (Figure 4A; Figures S3A
and S3B). The rod signature was indistinguishable from normal
differentiated rods, and the progenitor signature was indistin-
guishable from that of normal progenitor cells. More impor-
tantly, the human retinoblastomas also had robust signatures
for amacrine cells and cone photoreceptors (Figure 4A). The
strongest cell type-specific signature for mouse retinoblas-
tomas was the amacrine cell score; these tumors also had
a pronounced expression of genes that regulated the G2/M
phase in progenitor cells (Figure 4B; Figures S3A and S3B).
Statistical analysis of the human and mouse retinal cell type
signatures identified the amacrine cell signature and the rod
cell signature as the most similar and the most distinct, respec-
tively, across species (Figure 4C; Table S6 and Supplemental
Experimental Procedures).
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Differentiation of RetinoblastomaWhen signatures were compared, correlations became
evident between rod and cone scores, G2/M and progenitor
scores, and between amacrine and ganglion cell scores along
a continuum for both mouse and human retinoblastomas (Fig-
ure S3B). The cell type signatures that are normally incompatible
(i.e., progenitor versus rod or amacrine versus rod) coexisted
in the same tumors (Figures 4D and 4E; Figure S3B). Immunos-
taining for cell type markers and scoring of dissociated cells
provided additional evidence that individual cells express
multiple retinal differentiation pathways (Figures S3C–S3F;
data not shown). These analyses suggest that human andmouse
retinoblastomas represent a true hybrid of progenitor cells,
photoreceptors, and amacrine interneurons.
To extend these observations and perform a broader, unbi-
ased analysis of individual tumor cells, we isolated retinoblas-
toma cells from one of our orthotopic xenografts (SJ-RB39)
and performed single-cell gene expression array analysis, as
done previously (Cherry et al., 2009; Roesch et al., 2008;
Trimarchi et al., 2008). These data confirmed that individual
retinoblastoma cells in humans or mice express a mixture of
differentiation programs for photoreceptors, amacrine cells,
and progenitor cells (Figures 4F–4I; Figures S3G–S3I).Multiple Differentiation Pathways in Human Orthotopic
Retinoblastoma Xenografts
The expression of multiple differentiation pathways in primary
retinoblastomas may reflect contamination of normal retinal
neurons in the tumors. To test this possibility, we established or-
thotopic xenografts of three human retinoblastomas (SJ-RB39,
SJ-RB41, and SJ-RB42; see Figure 1) by injecting primary tumor
cells into the vitreous of SCIDmice. For comparison, we also ob-
tained a previously described orthotopic xenograft (MSKCC176)
(Xu et al., 2009). If normal retinal cells contaminate primary
tumors, then they would be rapidly overgrown in the orthotopic
xenografts, and any contribution from the recipient mouse retina
would not be detected because our probes and primers are
specific for the human sequences. We carefully documented
the morphology of the live cells and tissue specimens by TEM
and intraocular histopathologic analyses (Figures 5A–5E; Fig-
ure S4). Tumor initiation, expansion, and progression were
monitored using a digital retinal camera (Figure 5F), fluorescein
angiography (Figure 5G), and weekly inspection for anterior
chamber invasion (Figure 5H). The gene expression profile for
the primary tumors used for the SJ-RB xenografts were repre-
sentative of the overall population of human retinoblastomas in
our study; minimal change occurred over the three passages in
the vitreous of the eyes of the SCID mice for the SJ-RB xeno-
grafts or the MSKCC176 xenograft (Figure 5I; Table S7). The
cell type signatures for these orthotopic xenografts were very
similar to that of the primary human tumors (Figure 5J).
Human retinoblastomas express high levels of the MDMX
gene and the MDMX protein (Laurie et al., 2006). We con-
firmed that primary human retinoblastomas and the SJ-RB and
MSKCC176 orthotopic xenografts express high levels of MDMX
mRNA and protein (Figures 5K–5M and data not shown). In
contrast, MDM2 levels were below the limit of detection in any
of the human tumor xenografts or cell lines in our study, including
the MSKCC176 xenograft (Figures 5K–5N). These data suggestthat the orthotopic xenografts provide an ideal model in which
to study inhibitors of the MDMX-p53 interaction.
Neuroanatomical and Neurochemical Features
of Amacrine Cells in Retinoblastoma
In addition to their molecular signatures, each retinal cell type
exhibits distinct morphological and anatomical features that
can be quantified on TEM images. We established a series of
six morphometric features of cell bodies and ten neuroanatom-
ical features of cellular processes that allowed us to unambigu-
ously distinguish the different classes of retinal cell types
(Figures 6A–6E; Table S8 and Table S9). On the basis of these
morphometric and neuroanatomical measurements, the human
and mouse retinoblastomas most closely resembled amacrine
interneurons than photoreceptors, bipolar cells, or Mu¨ller glia
(Figures 6A–6G; Table S8 and Table S9). One of themost striking
features of the neuroanatomical analysis of plexus regions was
the presence of dense core vesicles in human andmouse retino-
blastomas (Figures 6E and 6F). These structures were present in
the same tumors with connecting cilia and basal bodies (Fig-
ure 6G). Dense core vesicles are a hallmark of monoamine
neurotransmitter secretion, and the only cell type in the retina
that has dense core vesicles and produces monoamines are
amacrine cells (Macneil et al., 1999; MacNeil and Masland,
1998). We used HPLC-ED to measure the levels of dopamine,
serotonin, and their metabolites in normal retinae, mouse retino-
blastoma, and human retinoblastoma xenografts (Figures 6H
and 6I). The levels of these molecules in human and mouse
retinoblastoma were similar to those found in normal retinae.
Functional Significance of Neuronal Differentiation
in Retinoblastoma
To begin to explore the functional significance of the features of
neuronal differentiation in retinoblastoma, we searched our data-
base of pediatric solid tumor cell line sensitivity to FDA-approved
drugs and well-characterized cytotoxic agents (A.A. Shelat and
R.K. Guy, unpublished data). This database includes dose-
response data in triplicate for more than 600 compounds on 21
different solid tumor cell lines including retinoblastoma, osteo-
sarcoma, rhabdomyosarcoma, and neuroblastoma. The Y79
and Weri1 retinoblastoma cell lines were found to be uniquely
sensitive to a subset of antipsychotic agents. Cheminformatic
analysis showed that the agents were all derivatives of phenothi-
azines, which are broad-acting monoamine receptor inhibitors,
including dopamine, serotonin, histamine, and epinephrine
receptors. These intriguing results prompted us to analyze
neurotransmitter receptors, transporters, and regulators in detail
and to study their functional significance for retinoblastoma
growth and survival.
We first identified genes encoding all major neurotransmitter
receptors and transporters in the retina that were represented
on the gene expression microarrays (175 genes, 212 probe
sets, Table S10). For example, we reviewed the data for 29 genes
(43 probe sets) involved in GABA neurotransmission. Among
those 29 genes, only 6 had expression levels for either tumor
or normal retina greater than Log2 = 8, and only 3 genes
(GABBR1, GABBR2, and GABRB3) were expressed in primary
human retinoblastomas or cell lines at levels similar to or greater
than that in normal retina (Figure 7A). Those three genes wereCancer Cell 20, 260–275, August 16, 2011 ª2011 Elsevier Inc. 265
Figure 4. Retinal Cell Type-Specific Gene Signatures for Human and Mouse Retinoblastomas
(A and B) Box plots of normalized relative scores for cell type-specific gene signatures for individual retinal cell types and the G2/M signature. Red bars indicate
themedian of the actual cell type score to serve as a benchmark. Ortholog-matched unigenes were used for these comparisons. All 52 human arrayswere used in
(A), and all 120 mouse arrays were used in (B). The bottom and top of the boxes are the 25th and 75th percentile and the line in the middle is the 50th percentile.
The lines represent one standard deviation above and below the mean and data points outside of those lines represent outliers.
(C) Statistical analysis of cell type-specific score differences for mouse and human retinoblastomas based on a t test.
(D and E) Two-dimensional plots of human retinoblastoma gene expression array scores for retinal cell type signatures. Vertical dashed lines represent the lower
limit for progenitor signature for retinal progenitor cells or amacrine signature for retinal amacrine cells. Horizontal dashed line represents the lower limit for rod
signature for rod photoreceptors. Rods are red, amacrine cells are green, progenitor cells are light blue and retinoblastomas are black.
(F) Differential interference contrast (DIC) image of dissociated SJ-39 xenograft used for single-cell microarrays. In the upper panel, a tumor cell is picked (arrow)
and transferred to a new dish (lower panel) to verify that a single cell was isolated (arrow). Scale bars: 5 mm.
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Differentiation of Retinoblastomaselected for further analysis (see below). Identical criteria were
used to select genes involved in glutamate, glycine, melatonin,
histamine, epinephrine, dopamine, serotonin, cholinergic/
muscarinic, and opioid signaling in neurons (Figure 7A). In the
gene expression array analysis, the monoamine receptors and
pathways (dopamine, histamine, epinephrine, and serotonin)
were most abundant in retinoblastoma, but other pathways
(GABA, glycine, and glutamate) were also expressed (Figures
7A and 7B).
To validate the gene expression microarray data, we gener-
ated TaqMan real-time RT-PCR probes for each gene that was
expressed in the human retinoblastomas and analyzed expres-
sion in the SJ39 xenograft, human retinoblastoma cell lines,
and normal retinae. In total, 96 genes were analyzed in duplicate
for each sample (complete data set available upon request).
Several of the monoamine/catecholamine receptors including
serotonin receptors (HTR3A, HTR1E), a dopamine receptor
(DRD5), and a histamine receptor (HRH3) were expressed in reti-
noblastoma at levels equal to or greater than normal human
retina (Figure 7B). In addition, several of the genes involved in
the biosynthesis of catecholamines such as TPH1, which
encodes the rate-limiting enzyme for serotonin synthesis, and
PHOX2A, which regulates genes that are important for dopamine
neurotransmission, were expressed at high levels in the human
retinoblastomas (Figure 7B). All three alpha-2 adrenergic recep-
tors (ADRA2A, ADRA2B, and ADRA2C) were expressed in the
tumors (Figure 7B). These proteins regulate the catecholamine-
mediated inhibition of adenylate cyclase through the action of
G-proteins in neurons. Immunoblotting confirmed the expres-
sion of these proteins (Figure 7C and data not shown).
Although most genes involved in neurotransmission that are
upregulated in retinoblastomas are those found in amacrine cells
and involved in catecholamine/monoamine signaling, there were
some that are from other pathways in the retina including GABA,
glycine, and glutamate. It is possible that proteins important in
other neurotransmitter pathways are expressed in retinoblas-
toma and are functionally important but were expressed at levels
below the limit of detection in our molecular studies. Therefore,
to determine which of the major neurotransmitter pathways are
functionally relevant, we performed a series of pharmacological
experiments with retinoblastoma cell lines in culture. We tested
13 well-characterized pharmacological agents targeting each
pathway in all 3 retinoblastoma cell lines (Weri1, Y79, and
RB355) and a nonneuronal cell line (BJ) in triplicate dose-re-
sponse experiments (Table 1 and data not shown). Only the
broad-acting monoamine transporter inhibitors showed any
activity in these experiments, and fluphenazine and chlorproma-
zine were the most active among those agents (Figures 7D and(G) Ethidium bromide-stained agarose gel with the amplification product from four
Molecular weight markers (1.0 and 2.0 kb) are indicated with arrowheads.
(H) Cell type-specific scores for 1 of the 20 individual SJ-39 xenograft tumor cells
cell; the gray box plot is the data from all 52 human retinoblastomas; and the red b
and top of the boxes are the 25th and 75th percentile and the line in the middle is th
the mean and data points outside of those lines represent outliers.
(I) Two-dimensional plot of SJ-39 xenograft single-cell gene expression array sc
cells are green, progenitor cells are light blue and retinoblastomas are gray. The
derived from this xenograft are shown in blue.
See also Figure S3 and Table S5 and Table S6.7E and Table 1). We analyzed the receptor-binding profile of
these two agents by using data from the PDSP Ki database
(http://pdsp.med.unc.edu/pdsp.php). Using this approach, we
identified another pharmacological agent with a similar profile
(thioridazine) and tested it in dose response studies against all
three retinoblastoma cell lines in triplicate. This compound
gave results similar to fluphenazine and chlorpromazine (Table
1). None of the agents were active against the BJ cells (data
not shown). In addition, more specific catecholamine pathway
inhibitors such as the selective serotonin reuptake inhibitors
(SSRIs) had no effect on retinoblastoma cell lines (data not
shown). These data suggest that broad inhibition of multiple
classes of monoamine receptors is required to affect retinoblas-
toma cells in culture.
To test whether the inhibition of monoamine receptors
affected retinoblastoma cell proliferation and/or cell viability,
we exposed the three retinoblastoma cell lines to different
concentrations of fluphenazine and chlorpromazine for 24 hr
and then labeled the cells in S-phase with a 1 hr BrdU pulse.
We performed immunostaining for BrdU and phospho histone
H3 (pH3) to monitor proliferation and activated caspase-3 to
monitor cell death (Figure 7F). Overall, the retinoblastoma cells
exhibited reduced BrdU and pH3 labeling with increasing
concentration of fluphenazine or chlorpromazine (Figure 7G).
There was no significant effect on the proportion of activated
caspase-3+ cells (Figure 7G).
To extend our observations to a more relevant in vivo model,
we tested the effect of these monoamine transporter inhibitors
on the orthotopic xenograft SJ-39. Twenty immunocompro-
misedmice were injected intravitreally with the SJ-39 retinoblas-
toma xenograft, and after 3 weeks, engraftment was confirmed
with retinal camera and fluorescein angiography. The 20 animals
were divided into four groups, and each group received a sub-
conjunctival injection of vehicle, topotecan/carboplatin, fluphen-
azine, or chropromazine once weekly for 3 consecutive weeks
in a double-blind study design. The tumor volume was then
measured in each of the 40 eyes by using MRI (Figures 7H and
7I), and histological analysis was performed (Figure 7J). Fluphen-
azine and chlorpromazine injections appeared to significantly
reduce tumor volume in vivo (Figure 7I), and this effect was
confirmed by histopathologic analysis (Figure 7J).
DISCUSSION
Since 1897, whenWintersteiner proposed that rosettes in retino-
blastoma reflect photoreceptor differentiation (Wintersteiner,
1897), the cell of origin and the cellular features of retinoblastoma
have been debated. Initially, the focus was on those features thatisolated SJ-39 xenograft cells prior to hybridization to gene expression arrays.
that was profiled in this study. The blue bar represents the scores for this single
ar is themedian score for normal cell populations used in this study. The bottom
e 50th percentile. The lines represent one standard deviation above and below
ores for rod photoreceptor and progenitor signatures. Rods are red, amacrine
primary tumor used to generate the xenograft is circled and the individual cells
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Figure 5. Orthotopic Xenografts of Human Retinoblastomas
(A) Differential interference contrast microscopy images of single dissociated cells from a primary human retinoblastoma (SJ-39) that was injected into the
vitreous of immunocompromised mice. Scale bars: 5 mm.
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rosettes. With advances inmicroscopy, histology, andmolecular
biology, the debate about the retinoblastoma cell of origin has
been revisited with a strong predilection toward photoreceptors
being the cell of origin (Dickson et al., 1976; Donoso et al., 1985,
1986; Glubrecht et al., 2009; Mirshahi et al., 1986; Ts’o et al.,
1970a, 1970b; Vrabec et al., 1989; Xu et al., 2009). However,
a number of independent studies suggested that retinoblas-
tomas may also have features of progenitor cells or interneurons
such as amacrine cells (Beemer et al., 1984; Donovan et al.,
2006; Glubrecht et al., 2009; Johnson et al., 2007; Kyritsis
et al., 1984a; Kyritsis et al., 1984b; Kyritsis et al., 1986; Tsokos
et al., 1986; Zhong et al., 2007). The possibility of a hybrid cell
with features of multiple cell types was not explored in these
previous studies. Our ability to perform single-cell gene expres-
sion array analysis provided us with an opportunity to distinguish
between these different possibilities.
Our analyses of human and mouse retinoblastomas showed
that individual retinoblastoma tumor cells express multiple
developmental programs for photoreceptors, interneurons, and
progenitor cells. This was surprising and unexpected, because
these developmental programs are never coexpressed in dif-
ferentiated cells or progenitor cells during retinogenesis. This
discovery underscores the challenges of assigning cell-of-origin
status without first establishing the full molecular and cellular
signature of a tumor. It is important to emphasize that these
studies do not necessarily indicate that a photoreceptor, inter-
neuron, or progenitor cell is the cell of origin for retinoblastoma.
Detailed cell-lineage studies will be required to definitively iden-
tify the cell of origin for retinoblastoma.
Molecular Characterization of Human and Mouse
Retinoblastomas
Unlike other human cancers that are readily divided into distinct
subtypes based on their molecular profiles, human retinoblas-
tomas are remarkably homogenous, and our data are in good
agreement with a small study of six tumors (Ganguly and Shields,
2010). In addition, retinoblastomas from six different mouse
strains were very similar to each other and to the human tumors.
We were surprised to learn that no single mouse strain emerged
as statistically more similar to the human tumors than the others.
However, subtle differences in the expression of photoreceptor
genes was found among some of the mouse tumors using unsu-(B–E) Representative TEM images of the SJ-39 xenograft and MSKCC176 xenog
were present in both xenografts (open arrowheads in D and E).
(F and G) Retinal camera image of the SJ-39 xenograft with a large focal tumor (a
(H) The SJ-39 xenograft is highly invasive and aggressive, as shown by anterior
(I) PCA of human retinoblastomas showing the addition of third-passage xenogra
-60R, and -8L are sublines of SJ-39.
(J) Box plot of the three SJ-RB retinoblastoma xenografts (SJ-RB39, SJ-RB41, SJ
are the 25th and 75th percentile and the line in the middle is the 50th percentile. T
points outside of those lines represent outliers. The red bars represent the med
retinoblastomas.
(K) Log2 expression of MDMX and MDM2 across all 52 human retinoblastomas.
(L) Immunoblot for MDMX and MDM2 in human retinoblastoma xenografts (SJ-R
week [FW] 12 and FW20). SJSA cells treated with MG132 were used as a positiv
(M and N) Quantification of the protein levels of the blots in (L). Each bar was the no
the level of expression in FW20 retina, which was set to 1.0 (dashed line). Abbre
See also Figure S4 and Table S7.pervised hierarchical cluster analysis. There are several possible
explanations for these differences in photoreceptor gene ex-
pression. The cluster with the higher photoreceptor gene expres-
sion may have had some contamination from the normal retina.
Alternatively, the different clusters may have had different cells
of origin, and further lineage studies on the different genetic
backgrounds will be required to distinguish between these
possibilities.
Photoreceptor Signature in Retinoblastoma
Many of the studies on retinoblastoma differentiation con-
ducted over the past century have focused on photoreceptor
features, including a recent study linking retinoblastomas origin
to cone photoreceptors (Xu et al., 2009). Our data show that
retinoblastomas express molecular features of photoreceptors
and that the rod signature is more robust than the cone signa-
ture. More importantly, our morphometric and neuroanatomical
studies of these cells showed few cellular features of photore-
ceptors. This raises the possibility that the gene regulatory
network that controls photoreceptors is deregulated in human
retinoblastomas, and to a lesser degree, in mouse retinoblas-
tomas, but it does not necessarily mean that the tumors
originated from these cells. Interestingly, a large number of
photoreceptor genes are also expressed in medulloblastomas
(Kool et al., 2008; Vincent et al., 2003); yet, those tumors clearly
do not originate from a photoreceptor. This may indicate
that the transcriptional pathways involved in photoreceptor
differentiation are nonspecifically deregulated in a variety of
tumors of the CNS leading to false conclusions about the cell
of origin.
Amacrine and Progenitor Cell Features
in Retinoblastoma
In a previous study of mouse retinoblastomas, we suggested
that these tumors have features of amacrine, horizontal, and
progenitor cells (Macpherson and Dyer, 2007). Very few genes
distinguish amacrine cells from horizontal cells, thereby making
these cells difficult to distinguish in our analysis. The unexpected
result from this study was the degree of amacrine cell differenti-
ation in human retinoblastomas and xenografts derived from
primary tumors. Indeed, the cell type signature, morphometric,
neuroanatomical, and neurochemical features that are most
common across human and mouse retinoblastomas are thoseraft showing tightly packed clusters of cells and rosettes. Dense core vesicles
rrow) from an early-stage tumor with corresponding fluorescein angiography.
chamber invasion (arrow).
fted samples (blue) and the MSKCC176 and 177 samples (yellow). SJ39X-40R,
-RB42), with respect to their cell type scores. The bottom and top of the boxes
he lines represent one standard deviation above and below the mean and data
ian for the cell types, and the green bars represent the median of the human
B and MSKCC), a retinoblastoma cell line (Y79), and human fetal retinae (fetal
e control for MDM2 immunoblotting.
rmalized value relative to GAPDH expression. The data were plotted relative to
viation: ON, optic nerve.
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Figure 6. Morphometric, Neuroanatomical, and Neurochemical Analyses of Retinoblastoma Cells
(A) Morphometric scoring of six measurements in more than 1000 human or mouse retinoblastoma cells on transmission electron micrographs. Each bar is the
sum of the score for the tumors, as comparedwith those of the normal cell populations. At least five independent fields from five independent biological replicates
were used for each sample.
(B–E) Neuroanatomical characterization of human and mouse retinoblastomas compared to those of normal retinae by using TEM. Representative images
and scoring of outer segments (B), inner segments (C), synaptic elements at the outer plexiform layer (OPL) (D), and those of the inner plexiform layer (IPL) (E)
are shown. Scoring for nine neuroanatomical features representative of different retinal cell types is shown. Each bar represents at least five independent fields
from five independent samples.
(F) Representative dense core vesicles from a human retinoblastoma.
(G) Representative basal body and connecting cilia from a human retinoblastoma.
(H and I) HPLC-ED measurements of dopamine and its metabolites (H) and serotonin and its metabolites (I). All histograms are mean ± SD. Abbreviations: bb,
basal body; cc, connecting cilium; dcv, dense core vesicle; os, outer segments; sv, synaptic vesicles.
See also Table S8 and Table S9.
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other tumors in the CNS exhibit this unique combination of
neuronal differentiation, which suggests that it is specific to reti-
noblastoma. However, this does not mean that retinoblastomas
in humans or mice arise from amacrine cells. The tumor’s cell of
origin may be completely independent of amacrine interneurons,
and because tumor suppressor or oncogenic pathways are de-
regulated during tumorigenesis, the amacrine differentiation
program may be activated.
It is widely believed that the initiating genetic lesion in the RB1
gene occurs in proliferating retinal progenitor cells during fetal
development. Retinal progenitor cells may be the cell of origin270 Cancer Cell 20, 260–275, August 16, 2011 ª2011 Elsevier Inc.for retinoblastoma, and the multiple differentiation programs
that are found in human and mouse retinoblastomas may reflect
themultipotent competence of retinal progenitor cells. Indeed, in
the single-cell gene expression array analysis of mouse retinal
progenitor cells, photoreceptor and interneuron genes were
often expressed in proliferating retinal progenitor cells (Trimarchi
et al., 2008).
Single-Cell Gene Expression Profiling
for Retinoblastoma
The single-cell gene expression profiling for the human retino-
blastoma xenograft provided important validation for the
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Differentiation of Retinoblastomacoexpression of multiple differentiation programs in individual
tumor cells. However, the PCR-amplification protocol that is
required for this method (35 cycles of amplification) could affect
the final representation of transcript abundance. A previous
study specifically designed to investigate this question found
a significant level (25%) of false positives associated with
exponential amplification of small amounts of starting material
(Iscove et al., 2002). In that same study, however, the authors
found a significant level of false negatives associated with
a linear-based amplification approach (Iscove et al., 2002).
Using a PCR-based single-cell profiling method in tissue culture
cells and the olfactory system, Tietjen et al. did not encounter
a high false-positive rate (Tietjen et al., 2003). This same
single-cell profiling method has been used extensively to
examine the transcriptomes of many different cells from retinal
progenitor cells (Trimarchi et al., 2008), retinal amacrine cells
(Cherry et al., 2009), neuronal progenitor cells (Kawaguchi
et al., 2008), hematopoietic stem cells (Ramos et al., 2006),
and olfactory neuron progenitors (Tietjen et al., 2003). Expres-
sion analyses of a large number of retinal progenitor and ama-
crine genes (>200) revealed a very high degree of correlation
(90%) between the microarray results and in situ hybridization
(ISH) experiments using both retinal cryosections and dissoci-
ated retinal cells (Cherry et al., 2009; Trimarchi et al., 2007,
2008). For approximately 10% of the genes examined, the
observed lack of correlation between the predicted gene expres-
sion pattern from the single-cell microarray data and the subse-
quent ISH staining pattern involved contamination in the single-
cell preparation (Trimarchi et al., 2007). Such contamination
arises from two main sources in retinal preparations. First, rod
photoreceptor cell outer segments are quite fragile and can
break during the dissociation, leading to the presence of rod
mRNAs in the media. Second, a tight connection between two
cell types, as there is between the RPE and PR cells, can also
lead to contamination (Trimarchi et al., 2007). Neither of these
is relevant to our study because the human orthotopic xenograft
was injected into the vitreous of the eye, andwhen the tumor was
removed for single-cell isolation, the retina and RPE were left
intact and connected to the sclera. Moreover, gene expression
arrays were performed using human gene chips, because the
tumor was a human orthotopic xenograft; thus, any contami-
nating mouse cells or transcripts would not have been detected
in this analysis.
The single biggest caveat to interpreting the single-cell data is
the difficulty in understanding whether the absence of a signal
arises due to a cell not expressing that particular gene or the
failure to sample that mRNA in the single-cell reverse-transcrip-
tion reaction. Thus, while we can say that retinoblastoma cells
clearly express multiple differentiation programs, we cannot
absolutely rule-out the possibility that we failed to detect low
levels of transcripts for some of the other cell types.
MDM2 and MDMX in Retinoblastoma
A recent hypothesis related to the retinoblastoma cell of origin
came from the observation that cell type-specific expression of
MDM2 occurs in cone photoreceptors in human retina and in
amacrine cells in mouse retina (Xu et al., 2009). This finding
provided a plausible mechanism in which cones are the cell of
origin for retinoblastoma in humans, and amacrine cells are thecell of origin in mice. It was hypothesized that high levels of
MDM2 in these cells predisposed them to tumorigenesis,
because MDM2 silences the p53 pathway and prevents cell
death. According to this hypothesis, the tumors maintain
MDM2 expression to suppress the p53 pathway, and the tumor
grows and spreads. In our study, we found that MDMX was the
predominant family member expressed in human retinoblas-
tomas. We propose that instead of MDM2, MDMX silences
p53 in human retinoblastomas, and future therapeutic efforts
focused on inhibiting MDMX may prove beneficial for these
patients.
Role of Neurotransmitter Signaling in Retinoblastoma
The amacrine differentiation of human and mouse retinoblas-
toma may be functionally significant for tumor survival and
progression. The most striking evidence for amacrine differenti-
ation at the cellular level came from the identification of dense
core vesicles in human and mouse retinoblastomas. However,
an important distinction is that the retinoblastoma cells appear
to express a mixture of receptors, transporters, and metabolic
genes for catecholamines, whereas individual amacrine neurons
are more restricted and can be subdivided based on catechol-
amine accumulation (i.e., serotonergic versus dopaminergic).
This hybrid-amacrine phenotype is consistent with the broader
theme of deregulation of multiple differentiation pathways in
the retinoblastoma tumors.
As reported previously, retinoblastomas produce catechol-
amines and other monoamines (Klaidman et al., 1993; Madtes
et al., 1985; Yorek et al., 1987). We found that several of the
receptors for monoamines are expressed, as are the genes
involved in the biosynthesis of monoamines and the regulation
of signaling through these receptors. However, out data show
that only the blockade of monoamine receptors, but not other
major neurotranmitter signaling pathways, reduces retinoblas-
toma growth and survival. Our interpretation of these data is
that retinoblastoma cells are engaged in an autocrine induction
of this pathway that is selective for catecholamines. All of the
major catecholamine/monoamine receptors stimulate the
MAPK pathway and provide an important mitogenic signal for
retinoblastoma. It may also explain why retinoblastomas form
in the retina because the amacrine-differentiation pathway can
be co-opted for mitogenic signaling followingRB1 gene inactiva-
tion. Additional studies will be required to determine whether
catecholamine signaling influences survival and growth through
the MAPK pathway or if it is required for some other aspect of
tumorigenesis.
One major caveat of these studies is that we were unable
to definitively identify an individual receptor that is important
for retinoblastoma proliferation. This suggests that the retino-
blastoma tumors have co-opted several monoamine neurotrans-
mitter signaling pathways from amacrine neurons. The mono-
amine neurotransmitter receptors themselves may not be the
critical autocrine receptor, but some other receptor family may
be expressed on the tumor cells that share downstream effec-
tors. By perturbing the monoamine neurotransmitter receptors,
we may be interfering with other autocrine signaling cascades
by competing for the same downstream effectors. In either
case, these data provide important insight into potential thera-
peutic targets for retinoblastoma.Cancer Cell 20, 260–275, August 16, 2011 ª2011 Elsevier Inc. 271
Figure 7. Inhibition of Neurotransmitter Receptors Reduces Retinoblastoma Growth In Vitro and In Vivo
(A) Analysis of neurotransmitter pathway gene expression in human retinoblastoma tumors and orthotopic xenograft. In this analysis, genes that were expressed
at levels equal to or greater than that in human retina and had a Log2 value ofR8.0 were included.
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Table 1. Inhibition of Neurotransmitter Receptors in Retinoblastoma
Compound Target Y79 EC50 (mM) Weri1 EC50 (mM) RB355 EC50 (mM)
Fluphenazine Monoamine receptors 7 7 5
Chlorpromazine Monoamine receptors 8 6 2
Thioridazine Monoamine receptors 10.5 8 7
Promazine Monoamine receptors 40 20 20
Triflupromazine Monoamine receptors 27 25 11
Promethazine Monoamine receptors 40 20 20
Levomepromazine Monoamine receptors 17 18 7
NBQX AMPA receptors No activity No activity No activity
Picrotoxin GABAA receptors No activity No activity No activity
Strychnine Glycine receptors No activity No activity No activity
APICA Metabotrpic receptors No activity No activity No activity
SKF97541 GABAB receptors No activity No activity No activity
Cancer Cell
Differentiation of RetinoblastomaEXPERIMENTAL PROCEDURES
Human Retinoblastoma Samples
Immediately following enucleation, a small incision wasmade in the sclera, and
forceps were used to extract a sample of tumor (3–5 mm3). Tumor specimens
from patients treated at St. Jude Children’s Research Hospital (St. Jude) were
placed in RPMI medium on ice and immediately processed for RNA isolation,
DNA isolation, TEM, and/or orthotopic xenografts. Samples from other institu-
tions were immediately placed in RNAlater (QIAGEN) and shipped to St. Jude
on ice. The tumors were removed from a diverse patient population, with
respect to clinical presentation, sex, and race. All experiments involving
human subjects were approved by the St. Jude Children’s Research Hospital
Institutional Review Board and informed consent was obtained.
Orthotopic Xenografts
Primary human retinoblastoma specimens were dissociated in a solution of
trypsin and phosphate-buffered saline (PBS) at 37C until a single-cell suspen-
sion was obtained. Total cell number was determined using a hemacytometer,
and the viability of the cells was estimated using a Guava cell analyzer. The
cells were collected by centrifugation and resuspended in warm RPMI with
10% fetal calf serum (FCS) at approximately 10,000 cells/ml. Approximately
50,000 cells (5 ml) were injected into each eye of anesthetized SCID mice
(B6.CB17-Prkdc < scid > SzJ; Jackson Labs). Virtually all tumor cells en-(B) Real-time RT-PCR for representative genes from the pathways shown in (A). E
The data were normalized to b-actin levels for each sample and plotted relative t
pathway; red bars correspond to the metabotropic glutamate receptors; the blue b
correspond to the glycine receptor-signaling pathway.
(C) Immunoblot for a subset of the proteins encoded by the genes in (B). Som
mammalian retina at detectable levels.
(D and E) Representative dose response for RB355 cells to fluphenazine and ch
triplicate samples. Viability was measured with Cell Titer-Glo and normalized to
presence of the compound.
(F) Representative immunostaining results for vehicle-treated (control) and flu
phosphohistone H3 (pH3), and activated caspase-3 as indicated. The DAPI nucle
typical immunopositive cells. In this study, the cells were treated for 24 hr with e
(G) Scoring of the proportions of BrdU+, pH3+, and activated caspase-3+ followi
concentration, 250 cells were scored in duplicate. The bars represent the mean
(H) Representative MRIs of the eyes of retinoblastoma mice with SJ-39 orthotop
(light area) in the normally dark vitreous or anterior chamber.
(I) The tumor volume was measured on MRIs of ten eyes for each treatment grou
group.
(J) Representative H&E staining of each treatment group showing retina, tumor, an
carboplatin; DIC, differential interference contrast microscopy; TPT, topotecan.
Scale bars: (F), 10 mm; (J), 50 mm. See also Table S10.grafted; tumor progression was monitored with a digital retinal camera, and
intraocular pressure was regularly measured. No tumor cells were out of the
intraocular environment for more than 60 min, and none of the tumors used
for orthotopic xenografts were maintained in culture. The MSKCC176 cells
were kindly provided by Dr. David Cobrinik (Memorial Sloan-Kettering Cancer
Center) (Xu et al., 2009).
Mouse Retinoblastoma
The p107- and p130-knockout mice were obtained from Dr. Tyler Jacks
(Massachusetts Institute of Technology); Chx10-Cre mice were obtained
from Dr. Connie Cepko (Harvard Medical School); p53Lox/Lox and RbLox/Lox
mice were obtained from the Mouse Models of Human Cancer Consortium at
the National Cancer Institute;MDMXTg mice were obtained from Dr. Gigi Loz-
ano (MD Anderson Cancer Center); and p130Lox/Lox mice were obtained from
Dr. Julien Sage (Stanford Medical School). Mice were monitored weekly for
signs of retinoblastoma and anterior chamber invasion. Moribund status was
defined as the point when tumor cells invaded the anterior chamber, and intra-
ocular pressure increased to the point of imminent ocular rupture. The St. Jude
Institutional Animal Care and Use Committee approved all animal procedures.
Gene Expression Arrays
RNA was extracted using TRIzol reagent (Invitrogen) per the manufacturer’s
instructions. RNA concentration was quantified using a NanoDrop 100ach bar represents the mean and standard deviation of duplicate experiments.
o normal human retina. Green bars correspond to the GABA neurotransmitter
ar corresponds to the kainite glutamate receptor subclass; and the yellow bars
e of these proteins (TPH1 and PHOX2A) are not normally expressed in the
lorpromazine. Each data point represents the mean and standard deviation of
the vehicle-treated cells. The cells were maintained in culture for 72 hr in the
phenazine-treated retinoblastoma cells. Red fluorescence indicates BrdU,
ar stain (blue) was overlaid with DIC to show cell morphology. Arrows indicate
ach agent.
ng treatment with fluphenazine or chlorpromazine. For each sample and drug
and standard deviation of triplicate experiments.
ic xenograft after three courses of indicated treatment. Arrows indicate tumor
p, and the bars represent the mean and standard deviation for each treatment
d vitreous for each cohort. All histograms are mean ± SD. Abbreviations: CBP,
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Differentiation of RetinoblastomaSpectrophotomer (Thermo Scientific) or a SpectroMax Plus384 spectropho-
tometer (Molecular Devices). RNA integrity was measured using Agilent Tech-
nologies 2100 Bioanalyzer Lab-on-a-chip system. Total RNA (100 ng) was
amplified using the Affymetrix Two-Cycle Eukaryotic Target Labeling Assay
per the manufacturer’s instructions (GeneChip Expression Analysis Technical
Manual). The detailed hybridization procedure for the Affymetrix GeneChip for
mouse 430_2.0 and human U133_2 are described in the Supplemental Exper-
imental Procedures. The Hartwell Center for Bioinformatics and Biotechnology
at St. Jude performed all Affymetrix chip procedures and data analysis.
ACCESSION NUMBERS
The array datawere deposited in theGEOpublic database (accession number:
GSE29686).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and ten tables and can be found with this article online at
doi:10.1016/j.ccr.2011.07.005.
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